3 Results for "

INCB7839

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "INCB7839" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-10293
CAS No.: 791828-58-5
Purity:  99.44%
Synonyms: INCB007839; INCB7839
Target:  

MMP

Research Areas:  

Cancer

Aderbasib (INCB007839) is a potent, orally active and target specific low nanomolar hydroxamate-based inhibitor of ADAM10 and ADAM17. Aderbasib exhibits robust antineoplastic activity and can be used for cancer research, including diffuse large B-cell non-Hodgkin lymphoma, HER2 + breast cancer, gliomas, et al .
loading...
    loading...
Cat. No.: HY-10293R
CAS No.: 791828-58-5
Synonyms: INCB007839 (Standard); INCB7839 (Standard)
Target:  

Reference Standards MMP

Research Areas:  

Cancer

Aderbasib (Standard) is the analytical standard of Aderbasib (HY-10293). This product is intended for research and analytical applications. Aderbasib (INCB007839) is a potent, orally active and target specific low nanomolar hydroxamate-based inhibitor of ADAM10 and ADAM17. Aderbasib exhibits robust antineoplastic activity and can be used for cancer research, including diffuse large B-cell non-Hodgkin lymphoma, HER2+ breast cancer, gliomas, et al .
loading...
    loading...
Cat. No.: HY-W703549
Synonyms: INCB007839-d3; INCB7839-d3
Aderbasib-d3 (INCB007839-d3) is deuterium labeled Aderbasib. Aderbasib (INCB007839) is a potent, orally active and target specific low nanomolar hydroxamate-based inhibitor of ADAM10 and ADAM17. Aderbasib exhibits robust antineoplastic activity and can be used for cancer research, including diffuse large B-cell non-Hodgkin lymphoma, HER2 +?breast cancer, gliomas, et al .
loading...
    loading...